Firm Profile > Viguié Schmidt & Associés > Paris, France
Viguié Schmidt & Associés Offices
146 BOULEVARD HAUSSMANN
Viguié Schmidt & Associés > The Legal 500 Rankings
Viguié Schmidt & Associés is one of the market's go-to-firms for high-stake corporate and commercial disputes. The firm is often called in to act in strategic shareholder conflicts, and also regularly handles listed and private company M&A disputes. The practice is increasingly involved in cross-border cases involving African investors. Notably, its successes on the commercial disputes side include a high profile positive outcome relating to a dispute in the electricity sector. Yves Schmidt and Olivier Loizon co-head the practice. Nicolas Viguié and Martin Donato are also key members.
‘They pay real attention to the specific aspects of a case and do not try to sell clients a “one size fits all” kind-of-offer. They spend time understanding clients’ cases in depth.’
‘Yves Schmidt is smart and close to his clients’.
Orco Property Group
Sony Music Entertainment France
At Viguié Schmidt & Associés, Etienne Gouesse is entirely dedicated to handling healthcare sector regulatory and litigation issues. Leading pharmaceutical companies and medical device manufacturers turn to him for assistance with high-profile issues, including pricing, marketing, product liability and litigation matters. In recent work, the practice defended clients in product liability proceedings regarding landmark vaccines and drug products. The team also provides regulatory advice in connection with M&A transactions and handles public sector healthcare procurement disputes. Iñaki Saint-Esteben brings his competition law expertise to the table.
Viguié Schmidt & Associés regularly acts for shareholders, directors of listed companies and private investors, and has recently been involved in multiple high-profile public tender offer cases. The group is also defending CEOs of listed companies and traders in AMF investigations and trials relating to insider dealing and misleading financial information claims. Nicolas Viguié and Yves Schmidt are highly regarded in the field.
‘A very dedicated team which thinks out of the box. Their work has impacted the way regulation is being written today.’
‘Unique expertise and an excellent network.’
‘Yves Schmidt is an outstanding lawyer, a unique specialist in stock-exchange litigation who has a high understanding of psychology and an excellent knowledge of the industry context.’
Viguié Schmidt & Associés has a six-lawyer team that runs a strong domestic competition practice which has been involved in many of the market's most significant domestic cartel cases, including several landmark cases in the food and mass retailer sectors. The group recently assisted a client facing investigations from the EU Commission and acted in a complex case before the French Polynesian Competition Authority. The team also acts in a high number of damage claim lawsuits following prior major domestic cartel condemnations. Finally, the firm also advises on several very notable merger control cases. Iñaki Saint-Esteben and Virginie Viallard are in charge.
Mergers and acquisitions Tier 4
‘High availability and reactivity, including associates.’
‘Proactive and business makers.’
Crédit Agricole / CASA
SNCF / Geodis
XL Airways / La Compagnie
Tax Tier 5
‘The team is highly available and demonstrates great level of technique’
‘The team is available, responsive and clear’
‘Christel Alberti demonstrates excellent technical and writing skills’
Sony Music Entertainment
XL Airways / La Compagnie
Groupe La Française
Viguié Schmidt & Associés > Firm Profile
Viguié Schmidt & Associés has been created as a result of the merger between French independent firms SLVF and Viguié Schmidt. The lawyers of the firm are active both in transactional work as well as in judicial proceedings, in connection with complex matters where stakes are high.
They are experienced professionals with a particular taste for complex negotiations and litigations. They represent their clients before judicial courts and regulatory authorities.
Advisors for strategic moments: Viguié Schmidt & Associés assists its clients on all their sensitive and complex legal issues. The firm’s lawyers are active in the main areas of business law. All of the partners are deeply involved in the matters handled by the firm; their thorough knowledge of the market, their actors and practices, adds a strategic dimension to their legal expertise.
A cornerstone of the firm’s activity, this practice encompasses notably acquisitions or mergers involving public or private companies, private equity transactions as well as joint ventures and other strategic agreements.
The firm has a first rate experience in advising on takeovers, whatever the context and sector involved. The firm also advises issuers on a full range of topics specific to listed companies as well as on stock exchange regulation.
The team also assists our clients in matters pertaining to credit and loan agreements, either for the needs of a particular transaction (acquisition or assets financing, refinancing) or in the context of their ordinary course activities.
The firm regularly advises its clients on share capital increases as well as on the issuance of complex securities. It also has a strong expertise in advising its clients on corporate governance matters.
The team also advise corporate officers, shareholders and creditors in the negotiation of restructuring schemes, both amicably (“conciliation”, “mandat ad hoc”) or in the context of insolvency proceedings.
The firm handles a full spectrum of matters from large and complex disputes as well as high profile litigations to significant routine issues for our clients. It has extensive experience in corporate, commercial and securities litigation, notably in shareholders’ actions and M&A-related litigation. The team also acts in commercial and investment treaty arbitrations under a variety of arbitral rules as well as ad hoc arbitrations.
The team advises and represents our clients in connection with stock market litigations and market abuses, controls of regulated entities, in particular before jurisdictions, the Autorité des marchés financiers (French Stock Markets Authority) and competent courts of appeals.
The firm represents clients to secure merger control approval by the French Competition Authority and the European Commission, or to object to a proposed transaction.
The team also assists our clients to ensure compliance of their business practices with antitrust law (cartel and abuse of dominant position) and represent them before the competition authorities and courts.
More generally, the team advises our clients on all questions or project of interest from a competition law perspective, or that may imply restrictive practices.
The firm advises clients on all the tax aspects of their transactions, in particular in the areas of mergers & acquisitions, LBOs (including management packages) and corporate reorganizations.
It offers general advice and expertise on any aspects of company and individual taxation.
The team also provides assistance in tax audit and litigation.
Tort and Healthcare Products Law
The team advises public and private companies on tort law matters, and assists them in determining a strategy aimed at avoiding possible litigations. We also represent them before civil, administrative and commercial courts.
Our team is active in health products law, helping our clients in understanding applicable regulations and assisting them in the management of litigations and of administrative decisions affecting their activities or products.
|Corporate M&A||François Bourrier-Soiffer|
|Corporate M&A||Louis Chenard|
|Corporate M&A||David Scemla|
|Corporate M&A||Yves Schmidt|
|Corporate M&A||Fabrice Veverka|
|Corporate M&A||Nicolas Viguié|
|Dispute Resolution||Martin Donato|
|Dispute Resolution||Etienne Gouesse|
|Dispute Resolution||Olivier Loizon|
|Dispute Resolution||Yves Schmidt|
|Dispute Resolution||Nicolas Viguié|
|Competition Law||Iñaki Saint-Esteben|
|Competition Law||Virginie Viallard|
|Tort and Healthcare Products Law||Etienne Gouesse|
|Tort and Healthcare Products Law||Iñaki Saint-Esteben|